organophosphonates has been researched along with 1,2-dipalmitoylphosphatidylcholine in 2 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (1,2-dipalmitoylphosphatidylcholine) | Trials (1,2-dipalmitoylphosphatidylcholine) | Recent Studies (post-2010) (1,2-dipalmitoylphosphatidylcholine) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 4,158 | 20 | 1,262 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgess, DJ; Khan, MA; Xu, X | 1 |
| Cheng, Z; Tsourkas, A | 1 |
2 other study(ies) available for organophosphonates and 1,2-dipalmitoylphosphatidylcholine
| Article | Year |
|---|---|
Predicting hydrophilic drug encapsulation inside unilamellar liposomes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenine; Chemistry, Pharmaceutical; Dimyristoylphosphatidylcholine; Drug Compounding; Feasibility Studies; Hydrophobic and Hydrophilic Interactions; Lipids; Models, Chemical; Models, Statistical; Nanotechnology; Organophosphonates; Osmolar Concentration; Particle Size; Phosphatidylcholines; Propane; Quaternary Ammonium Compounds; Surface Properties; Technology, Pharmaceutical; Tenofovir; Unilamellar Liposomes | 2012 |
Monitoring phospholipase A₂ activity with Gd-encapsulated phospholipid liposomes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Arachidonic Acids; Contrast Media; Drug Compounding; Drug Liberation; Elapidae; Gadolinium; Heterocyclic Compounds; Liposomes; Magnetic Resonance Imaging; Organometallic Compounds; Organophosphonates; Permeability; Phosphatidylethanolamines; Phospholipases A2; Polyethylene Glycols | 2014 |